Literature DB >> 2209385

The rationale for cryotherapy with a prophylactic scleral buckle for Zone I threshold retinopathy of prematurity.

H A Mintz-Hittner1, F L Kretzer.   

Abstract

Our current surgical protocol for Zone I threshold retinopathy of prematurity (ROP) has evolved over 15 years and is rationalized by increasing knowledge of two pathologic processes of ROP: 1) angiogenic stimulation of spindle cells (clinically invisible) near the vitreal surface of the avascular retina; and 2) tractional forces of myofibroblasts [clinically visible as extraretinal fibrovascular proliferation (EFP)] in the vitreous overlying the vascular retina. These two pathologic processes occur concomitantly with normal anterior ocular growth with a constant optic disc-macular distance. Our current surgical protocol for Zone I threshold ROP, involves complex surgeries to achieve success defined as a macula which always remains anatomically attached, but which may be distorted or ectopic. This protocol requires cryotherapy in at least two sessions. The first is to the avascular retina to destroy spindle cells. The second is to the EFP to destroy myofibroblasts and to the shunt to eliminate the site of origin of myofibroblasts. The protocol also requires the concomitant placement of a prophylactic scleral buckle to allow formation of a new complete ora serrata while remnant myofibroblasts contract and while anterior ocular growth continues.

Entities:  

Mesh:

Year:  1990        PMID: 2209385     DOI: 10.1007/bf02482617

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  7 in total

1.  The mechanism of the cryosurgical adhesion. IV. Electron microscopy.

Authors:  H Lincoff; I Kreissig
Journal:  Am J Ophthalmol       Date:  1971-03       Impact factor: 5.258

2.  An interpretation of retinopathy of prematurity in terms of spindle cells: relationship to vitamin E prophylaxis and cryotherapy.

Authors:  F L Kretzer; A R McPherson; H M Hittner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

3.  Retinopathy of prematurity: clinical implications of retinal development.

Authors:  F L Kretzer; H M Hittner
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

4.  Multicenter trial of cryotherapy for retinopathy of prematurity.

Authors:  W Tasman
Journal:  Arch Ophthalmol       Date:  1988-04

5.  Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1988-04

6.  Vitamin E protects against retinopathy of prematurity through action on spindle cells.

Authors:  F L Kretzer; R S Mehta; A T Johnson; D G Hunter; E S Brown; H M Hittner
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

7.  Retinal detachment in young premature infants with acute retrolental fibroplasia. Thirty-two new cases.

Authors:  A R McPherson; H M Hittner; R Lemos
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

  7 in total
  2 in total

1.  Scleral buckling surgery in stage 4 retinopathy of prematurity.

Authors:  B Ricci; A Santo; F Ricci; G Minicucci; F Molle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

2.  Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention.

Authors:  David K Coats
Journal:  Trans Am Ophthalmol Soc       Date:  2005
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.